Related references
Note: Only part of the references are listed.Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management
Matteo Marchetti et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
Nina H. Schultz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Andreas Greinacher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review
Theodore E. Warkentin
EXPERT REVIEW OF HEMATOLOGY (2019)
A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway
Johann Bartko et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathway
Sanjay Khandelwal et al.
BLOOD (2018)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
Adam Cuker et al.
BLOOD ADVANCES (2018)
Autoimmune heparin-induced thrombocytopenia
A. Greinacher et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Influence of Human Leukocyte Antigen (HLA) Alleles and Killer Cell Immunoglobulin-Like Receptors (KIR) Types on Heparin-Induced Thrombocytopenia (HIT)
Jason H. Karnes et al.
PHARMACOTHERAPY (2017)
Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review
Dilli Ram Poudel et al.
PLATELETS (2017)
Heparin-Induced Thrombocytopenia
Andreas Greinacher
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Spontaneous heparin-induced thrombocytopenia syndrome without any proximate heparin exposure, infection, or inflammatory condition: Atypical clinical features with heparin-dependent platelet activating antibodies
Takuya Okata et al.
PLATELETS (2015)
Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder
Theodore E. Warkentin et al.
BLOOD (2014)
Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type
Birgitte F. Sode et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010
Gregory W. Daniel et al.
TRANSFUSION (2012)
The mechanism of heparin-induced platelet aggregation
B. H. Chong et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery 'spontaneous' HIT
R. K. Pruthi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Hormonal contraception and risk of venous thromboembolism: national follow-up study
Ojvind Lidegaard et al.
BRITISH MEDICAL JOURNAL (2009)
A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia
D Juhl et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings
GK Lo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Share Paper
